Jennison Associates’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-15,077
Closed -$1.3M 695
2022
Q1
$1.3M Sell
15,077
-449
-3% -$36.9K ﹤0.01% 532
2021
Q4
$1.27M Buy
+15,526
New +$1.13M ﹤0.01% 592
2021
Q3
Sell
-22,324
Closed -$1.5M 724
2021
Q2
$1.5M Sell
22,324
-3,984
-15% -$247K ﹤0.01% 585
2021
Q1
$1.37M Buy
+26,308
New +$1.33M ﹤0.01% 583
2018
Q3
Sell
-17,953
Closed -$603K 702
2018
Q2
$603K Buy
+17,953
New +$558K ﹤0.01% 613
2015
Q1
Sell
-6,587
Closed -$334K 747
2014
Q4
$334K Buy
+6,587
New +$344K ﹤0.01% 707

Other funds holding THC

Jennison Associates's THC Position: Q2 2022 in Review

Jennison Associates sold out of Tenet Healthcare (THC) in Q2 2022, closing a stake of 15,077 shares — an estimated $1.3M sold.

Jennison Associates first reported a position in THC in Q4 2014 and held it in 6 quarters. The position peaked at $1.5M in Q2 2021. 371 funds tracked by Wall St. Rank hold THC as of Q2 2022.

  • Jennison Associates reported no remaining Tenet Healthcare position as of Q2 2022 after selling out during the quarter.
  • Jennison Associates sold 15,077 Tenet Healthcare shares in Q2 2022, an estimated $1.3M.
  • Jennison Associates first reported a position in Tenet Healthcare in Q4 2014 and held it in 6 quarters.
  • Jennison Associates's Tenet Healthcare position peaked at $1.5M in Q2 2021.
  • 371 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2022.

Based on Jennison Associates's 13F filing for Q2 2022, filed 2 Aug 2022.